Detalles de la búsqueda
1.
Comparative Safety of Pulsed Field Ablation and Cryoballoon Ablation Technologies for Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation: A Critical Literature Review and Indirect Treatment Comparison.
Adv Ther
; 41(3): 932-944, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38185778
2.
Comparative efficacy of ofatumumab versus oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons.
Ther Adv Neurol Disord
; 17: 17562864241239453, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38525490
3.
Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma.
Curr Med Res Opin
; 39(1): 81-89, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36271807
4.
Palbociclib versus abemaciclib in HR+/HER2- advanced breast cancer: an indirect comparison of patient-reported end points.
J Comp Eff Res
; 11(2): 109-120, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34751591
5.
Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis.
Mult Scler Relat Disord
; 66: 104031, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35841716
6.
Meta-analysis of ciltacabtagene autoleucel versus physician's choice therapy for the treatment of patients with relapsed or refractory multiple myeloma.
Curr Med Res Opin
; 38(10): 1759-1767, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35815818
7.
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer.
J Comp Eff Res
; 10(6): 457-467, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33626934
8.
Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses.
Curr Med Res Opin
; 37(11): 1933-1944, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34384311
9.
Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma.
Curr Med Res Opin
; 37(10): 1779-1788, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34256668
10.
The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis.
Curr Med Res Opin
; 36(7): 1145-1156, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32216597
11.
Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis.
Curr Med Res Opin
; 36(7): 1157-1166, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32220214
Resultados
1 -
11
de 11
1
Próxima >
>>